Transferring Hair Loss Treatment: Continuing Care with a Local Dermatologist

A quiet clinic consultation room with a wooden desk, chairs, a softly lit stone wall, and a dark monitor screen.

A smooth handover starts with a brief document that includes the following: the active ingredient and dosage of each medication, when you started using them, how your hair has responded, and any symptoms you have experienced.

Bring this note to your first appointment with a dermatologist or primary care doctor after returning home. Your local doctor can then determine whether to continue the same prescription, make adjustments, or refer you to another specialist.

Planning this step before you leave Japan matters. A U.S. survey of 93,492 residents, mostly covering dental care abroad, found that 5% of people who traveled abroad for medical care in the previous year reported a complication, and 67% of those people sought care after returning home.1

Contents

What to bring to your first appointment back home

A local doctor requires specific information about each medication, and a written note helps ensure these details are retained between visits.

Build a one-page handover note

Before leaving Japan, note the facts a new doctor will need. If your Japanese clinic provides an English summary, request a copy to keep with your travel documents.

  • Active ingredient and dose of each medicine
  • Date you started and how long you have taken it
  • Changes in hair density, shedding, or the scalp
  • Any side effects, even mild or brief ones
  • Other treatments, including topical medicine, injections, or supplements

Use simple wording. A primary care doctor may not recognize Japanese brand names, so providing the active ingredient and dosage is more helpful than just a product name.

Tell your home doctor how your hair loss treatment has worked

Progress is as important as the prescription. A new doctor must assess whether your current plan is effective before deciding to continue it.

Record the timeline and response

When tracking your hair growth progress, note the start date and any changes monthly. Hair growth tends to be slow, so doctors will look for changes over several months rather than expecting immediate results. If you have clinic photos, include them or describe what they depict.

Treatment studies often measure progress with hair counts, the doctor’s rating, and photos taken under the same conditions. Doctors also use a magnified view of the scalp to follow how the hair responds. Your local doctor can use the same markers to judge whether to continue the plan.

List every other treatment

Topical minoxidil, injected treatments, medicated shampoo, and supplements can all change how the scalp looks. List each one with its name, dose or frequency, and the month it was used.

Injected treatments and procedures may not be available locally, but the record still helps the doctor understand what was already tried.

PSA tests and side effects to mention

It is important to inform both your local doctor and any doctor who orders tests about two key details: PSA testing and mood changes.

Three details your next doctor should see

Share these three items at the first visit, even if the doctor does not ask for them.

Detail to shareWhy it mattersWhere to find it
PSA test warningFinasteride and dutasteride can lower PSA. The doctor should interpret the result with that context.Treatment summary from your Japanese clinic
Mood changesThe Japanese package insert tells patients with suicidal thoughts to stop the medicine and contact a doctor promptly.Japanese package label guidance
Medicine name and datesThe local doctor needs the active ingredient, dose, and duration before prescribing or changing anything.Prescription records or English summary

If you are taking finasteride or dutasteride and a clinician orders a PSA test, be sure to inform them. These medications can lower PSA levels, and the doctor needs this information to interpret the results accurately.

Additionally, report any experiences of low mood, thoughts of self-harm, or sexual side effects, such as erectile dysfunction or reduced sex drive.

A meta-analysis of 15 randomized trials found a 1.57-fold higher risk of sexual side effects among men taking these medicines for male pattern hair loss.2

Your local doctor needs this history to decide whether the medicine still works for you.

Choosing a local doctor to continue hair loss treatment

A dermatologist is the usual choice, but a primary care doctor can also take over when the treatment is straightforward. Whether that doctor can prescribe the same medicine depends on your country’s rules and your health coverage.

A European guideline was written to help both dermatologists and general practitioners choose effective, safe treatments. A primary care doctor may handle the first checks and refer you to a dermatologist if needed.

Before you leave, ask your Japanese doctor whether they can share records or speak with your local doctor if questions come up. At AGA Medical Care Clinic, the same doctor stays with you throughout treatment, and the clinic can issue medical records and other documents in English.

Arrange to see your local doctor before your current supply runs out. Stopping treatment can allow hair loss to resume, and the aim is to switch without a gap.

Ask the local doctor what monitoring makes sense in their system. Dermatology follow-ups may look different from the visits you had in Japan, but a written plan can make the transition easier.

Research on how to keep care continuous after medical travel is still limited, which makes a clear written record worth carrying.

If you are planning treatment at AGA Medical Care Clinic, our doctors will listen to your concerns, goals, and questions during a consultation, including how you plan to continue care at home. You can contact our clinics in Tokyo and Yokohama, Japan through the pages below.

Frequently asked questions

Will my home doctor prescribe the same medicine I took in Japan?

Some will, and some will not. Approval and prescribing rules differ by country, and a doctor cannot decide until they see the active ingredient, dose, and duration. Bring those details and ask what is available locally.

What should I take to the first appointment?

Take the one-page handover note, your medicine packaging, any English treatment summary, and clinic photos if you have them. A written list is enough if the original packaging is no longer available.

Can my Japanese doctor and home doctor talk to each other?

Ask before you leave, because direct contact may be possible depending on the clinic. At AGA Medical Care Clinic, you can ask whether the doctor can respond to a written question from your local doctor.

What if my medicine runs out before the handover is complete?

Plan the first local appointment before your supply gets low. If you may run out before that appointment, ask your prescribing doctor in Japan what to do.

References

1. Stoney, R. J., Kozarsky, P. E., Walker, A. T., & Gaines, J. L. (2022). Population-based surveillance of medical tourism among US residents from 11 states and territories: Findings from the Behavioral Risk Factor Surveillance System. Infection Control and Hospital Epidemiology, 43(7), 870-875. https://doi.org/10.1017/ice.2021.245

2. Lee, S., Lee, Y. B., Choe, S. J., & Lee, W. S. (2019). Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Acta Dermato-venereologica, 99(1), 12-17. https://doi.org/10.2340/00015555-3035

Alessandrini, A., Starace, M., D’Ovidio, R., Villa, L., Rossi, A., Stan, T. R., Calzavara-Pinton, P., & Piraccini, B. M. (2020). Androgenetic alopecia in women and men: Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines. Giornale Italiano di Dermatologia e Venereologia, 155(5), 622-631. https://doi.org/10.23736/S0392-0488.19.06399-5

Blumeyer, A., Tosti, A., Messenger, A., Reygagne, P., Del Marmol, V., Spuls, P. I., Trakatelli, M., Finner, A., Kiesewetter, F., Trüeb, R., Rzany, B., Blume-Peytavi, U., & European Dermatology Forum (EDF) (2011). Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. Journal der Deutschen Dermatologischen Gesellschaft, 9 Suppl 6, S1-57. https://doi.org/10.1111/j.1610-0379.2011.07802.x

Gupta, A. K., Venkataraman, M., Talukder, M., & Bamimore, M. A. (2022). Finasteride for hair loss: a review. The Journal of Dermatological Treatment, 33(4), 1938-1946. https://doi.org/10.1080/09546634.2021.1959506

Mella, J. M., Perret, M. C., Manzotti, M., Catalano, H. N., & Guyatt, G. (2010). Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Archives of Dermatology, 146(10), 1141-50. https://doi.org/10.1001/archdermatol.2010.256

Xu, T., Wang, W., & Du, J. (2020). An Integrative Review of Patients’ Experience in the Medical Tourism. Inquiry: A Journal of Medical Care Organization, Provision and Financing, 57, 46958020926762. https://doi.org/10.1177/0046958020926762

Share this article
  • URL copied!
  • URL copied!
Contents